Treatment of Severe Anxiety in Patients with ADHD

Introduction to Treatment

The American Academy of Child and Adolescent Psychiatry recommends increasing escitalopram to 20 mg daily and adding cognitive behavioral therapy (CBT) or dialectical behavior therapy (DBT) for severe anxiety disorders, as the combination of SSRI with structured psychotherapy demonstrates superior efficacy compared to medication alone 1

Escitalopram 20 mg has demonstrated statistically significant superiority over 10 mg in reducing anxiety symptoms in controlled trials, allowing 4-8 weeks at the increased dose to evaluate full clinical response 1

DBT specifically addresses ADHD-related impairments through four modules: mindfulness, distress tolerance, interpersonal effectiveness, and emotion regulation 2, 3
Studies demonstrate that DBT reduces both ADHD symptoms and comorbid anxiety/depression in adults with ADHD 2, 3
The American Academy of Child and Adolescent Psychiatry recommends monitoring treatment response every 2-4 weeks using standardized anxiety scales like the GAD-7 1

Stimulants do not worsen anxiety when ADHD is adequately treated; in fact, untreated ADHD can exacerbate anxiety symptoms 4
Monitor for stimulant-related side effects including sleep disturbances, appetite suppression, and cardiovascular changes (blood pressure, pulse) 4

Switch to an SNRI (venlafaxine), which demonstrates slightly greater efficacy for treatment-resistant anxiety compared to continuing SSRI therapy, though with higher rates of nausea 1
Alternative SSRI options include sertraline or paroxetine, which have comparable efficacy profiles for anxiety disorders 5

Assess response every 2-4 weeks initially using GAD-7 scores to track anxiety symptom reduction 1
Screen for suicidality at each visit, especially during the first months and following dose adjustments 1
Evaluate ADHD symptom control to ensure lisdexamfetamine remains effective at current dosing 4

Do not discontinue lisdexamfetamine due to anxiety concerns; untreated ADHD can worsen anxiety and functional impairment 2, 4
Avoid premature medication switching before allowing adequate trial duration (8-12 weeks) at therapeutic escitalopram dose 1
Do not add benzodiazepines for anxiety management, as they carry dependence risk and may impair ADHD treatment response 1
Ensure psychotherapy is evidence-based (CBT or DBT), as supportive counseling alone shows inferior outcomes 1, 2